MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression AE Frampton, L Castellano, T Colombo, E Giovannetti, J Krell, J Jacob, ... Gastroenterology 146 (1), 268-277. e18, 2014 | 187 | 2014 |
Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer A Harrod, J Fulton, VTM Nguyen, M Periyasamy, L Ramos-Garcia, CF Lai, ... Oncogene 36 (16), 2286-2296, 2017 | 183 | 2017 |
Mammosphere formation assay from human breast cancer tissues and cell lines Y Lombardo, A de Giorgio, CR Coombes, J Stebbing, L Castellano Journal of visualized experiments: JoVE, 2015 | 152 | 2015 |
TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression S Ottaviani, J Stebbing, AE Frampton, S Zagorac, J Krell, A de Giorgio, ... Nature communications 9 (1), 1845, 2018 | 123 | 2018 |
Growth Arrest-Specific Transcript 5 Associated snoRNA Levels Are Related to p53 Expression and DNA Damage in Colorectal Cancer J Krell, AE Frampton, R Mirnezami, V Harding, A De Giorgio, ... PloS one 9 (6), e98561, 2014 | 93 | 2014 |
Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTEN A de Giorgio, J Krell, V Harding, J Stebbing, L Castellano Molecular and cellular biology, 2013 | 92 | 2013 |
Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferation FG Pinho, AE Frampton, J Nunes, J Krell, H Alshaker, J Jacob, ... Cancer research 73 (19), 5936-5948, 2013 | 88 | 2013 |
TP53 regulates miRNA association with AGO2 to remodel the miRNA–mRNA interaction network J Krell, J Stebbing, C Carissimi, AF Dabrowska, A De Giorgio, ... Genome research 26 (3), 331-341, 2016 | 67 | 2016 |
The p53 miRNA interactome and its potential role in the cancer clinic J Krell, AE Frampton, T Colombo, TMH Gall, A De Giorgio, V Harding, ... Epigenomics 5 (4), 417-428, 2013 | 36 | 2013 |
The role of TP53 in miRNA loading onto AGO2 and in remodelling the miRNA–mRNA interaction network J Krell, J Stebbing, AE Frampton, C Carissimi, V Harding, A De Giorgio, ... The Lancet 385, S15, 2015 | 26 | 2015 |
Noncoding RNAs and the control of signalling via nuclear receptor regulation in health and disease P Cathcart, W Lucchesi, S Ottaviani, A De Giorgio, J Krell, J Stebbing, ... Best practice & research Clinical endocrinology & metabolism 29 (4), 529-543, 2015 | 22 | 2015 |
SCIRT lncRNA restrains tumorigenesis by opposing transcriptional programs of tumor-initiating cells S Zagorac, A de Giorgio, A Dabrowska, M Kalisz, N Casas-Vila, ... Cancer Research 81 (3), 580-593, 2021 | 21 | 2021 |
Noncoding RNAs and the control of hormonal signaling via nuclear receptor regulation S Ottaviani, A de Giorgio, V Harding, J Stebbing, L Castellano J Mol Endocrinol 53 (2), R61-70, 2014 | 15 | 2014 |
Crosstalk-induced loss of miR-126 promotes angiogenesis A De Giorgio, L Castellano, J Krell, J Stebbing Oncogene 33 (28), 3634-3635, 2014 | 15 | 2014 |
Mistletoe: for cancer or just for Christmas? A de Giorgio, J Stebbing The Lancet Oncology 14 (13), 1264-1265, 2013 | 12 | 2013 |
Cannabis and cancer: reality or pipe dream? P Cathcart, A de Giorgio, J Stebbing The Lancet Oncology 16 (13), 1291-1292, 2015 | 11 | 2015 |
Garlic: a stake through the heart of cancer? A de Giorgio, J Stebbing The Lancet Oncology 17 (7), 879-880, 2016 | 6 | 2016 |
SCIRT lncRNA slows the formation of tumour initiating cells in breast cancer A de Giorgio, L Castellano Oncoscience 8, 74, 2021 | 1 | 2021 |
Long and short noncoding RNAs in the control of cancer stem cell traits AJR de Giorgio Imperial College London, 2019 | | 2019 |
Use of CRISPR-Cas9-mediated knockin mutagenesis of ESR1 mutations in metastatic breast cancer allow functional analysis and evaluation of treatment options J Fulton, A Harrod, V Nguyen, M Periyasamy, LR Garcia, CF Lai, ... BREAST CANCER RESEARCH AND TREATMENT 159 (1), 193-193, 2016 | | 2016 |